DTC
Deep Track Capital Portfolio holdings
AUM
$3.11B
This Quarter Return
+37.62%
1 Year Return
+13.6%
3 Year Return
+265.73%
5 Year Return
–
10 Year Return
–
AUM
$2.29B
AUM Growth
+$2.29B
(+13%)
Cap. Flow
-$39M
Cap. Flow
% of AUM
-1.7%
Top 10 Holdings %
Top 10 Hldgs %
46.99%
Holding
74
New
13
Increased
16
Reduced
22
Closed
16
Top Buys
| 1 |
Insmed
INSM
|
$85.2M |
| 2 |
Biogen
BIIB
|
$83.1M |
| 3 |
Sarepta Therapeutics
SRPT
|
$68.4M |
| 4 |
Ionis Pharmaceuticals
IONS
|
$45.5M |
| 5 |
AUTL
Autolus Therapeutics
AUTL
|
$28.5M |
Top Sells
| 1 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
$110M |
| 2 |
NovoCure
NVCR
|
$98.3M |
| 3 |
BioMarin Pharmaceuticals
BMRN
|
$56.8M |
| 4 |
Kura Oncology
KURA
|
$43.5M |
| 5 |
Fate Therapeutics
FATE
|
$29.4M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Immunovant
IMVT
$2.56B
| $172M | 7.24% | 9,710,000 -150,246 | -2% | -$2.67M |
|
|
ISEE
2
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
| $169M | 7.08% | 7,878,119 +878,119 | +13% | +$18.8M |
|
3
Jazz Pharmaceuticals
JAZZ
$7.75B
| $139M | 5.84% | 873,553 +12,553 | +1% | +$2M |
|
4
Travere Therapeutics
TVTX
$1.56B
| $96.4M | 4.05% | 4,582,000 +582,000 | +15% | +$12.2M |
|
5
Ascendis Pharma
ASND
$11.8B
| $85.5M | 3.59% | 700,000 -100,000 | -13% | -$12.2M |
|
|
6
Insmed
INSM
$28.8B
| $85.2M | 3.58% | +4,264,292 | New | +$85.2M |
|
|
BCYC
7
Bicycle Therapeutics
BCYC
$511M
| $83.4M | 3.5% | 2,819,045 -80,955 | -3% | -$2.4M |
|
|
VRNA
8
Verona Pharma
VRNA
$9.16B
| $83.3M | 3.5% | 3,187,415 +358,321 | +13% | +$9.36M |
|
|
9
Biogen
BIIB
$19.4B
| $83.1M | 3.49% | +300,000 | New | +$83.1M |
|
|
SWTX
10
DELISTED
SpringWorks Therapeutics
SWTX
| $80.9M | 3.4% | 3,109,886 +740,676 | +31% | +$19.3M |
|
|
KDNY
11
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
| $78.6M | 3.3% | 3,000,000 | – | – |
|
|
12
Sarepta Therapeutics
SRPT
$1.78B
| $68.4M | 2.87% | +528,244 | New | +$68.4M |
|
|
AGEN
13
Agenus
AGEN
$133M
| $64.8M | 2.72% | 27,000,000 +675,000 | +3% | +$1.62M |
|
14
4D Molecular Therapeutics
FDMT
$288M
| $59M | 2.48% | 2,656,901 -539,741 | -17% | -$12M |
|
|
HZNP
15
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $56.9M | 2.39% | 500,000 -962,800 | -66% | -$110M |
|
|
DICE
16
DELISTED
DICE Therapeutics, Inc. Common Stock
DICE
| $54.1M | 2.27% | 1,734,143 +734,143 | +73% | +$22.9M |
|
17
Viridian Therapeutics
VRDN
$1.5B
| $51.7M | 2.17% | 1,771,154 -199,136 | -10% | -$5.82M |
|
18
89bio
ETNB
$1.34B
| $49M | 2.06% | 3,850,000 +1,214,000 | +46% | +$15.5M |
|
19
Beam Therapeutics
BEAM
$1.66B
| $45.6M | 1.92% | 1,166,473 +166,473 | +17% | +$6.51M |
|
|
20
Ionis Pharmaceuticals
IONS
$6.79B
| $45.5M | 1.91% | +1,205,773 | New | +$45.5M |
|
|
ALLK
21
DELISTED
Allakos
ALLK
| $41.3M | 1.73% | 4,899,179 +380,604 | +8% | +$3.2M |
|
22
Repare Therapeutics
RPTX
$71.7M
| $40.1M | 1.68% | 2,727,606 -400,061 | -13% | -$5.88M |
|
|
ALBO
23
DELISTED
Albireo Pharma, Inc. Common Stock
ALBO
| $36.8M | 1.55% | 1,704,000 +593,376 | +53% | +$12.8M |
|
24
Pliant Therapeutics
PLRX
$101M
| $33.5M | 1.41% | 1,732,946 +333,202 | +24% | +$6.44M |
|
25
Dyne Therapeutics
DYN
$1.92B
| $31.1M | 1.31% | 2,684,200 -500,000 | -16% | -$5.8M |
|